Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Garg

Showing results (251-260 of 316) with videos related to

Pageof 32
Sort By:
Cancer Research|March 13, 2015
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulinAleksandra M Dudek-Perić, Gabriela B Ferreira, Angelika Muchowicz, et al.
Science Advances|July 19, 2024
Targeting conserved TIM3<sup>+</sup>VISTA<sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapyIsaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.
Cancer Research Communications|April 20, 2026
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell CarcinomaLisa Kinget, Edward Scott McTaggart, Octavie Demeulenaere, et al.
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
Cancer Immunology Research|November 24, 2021
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in CancerWard Celus, Ana I Oliveira, Silvia Rivis, et al.
Cell Reports|April 7, 2016
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityTania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancerJenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, et al.
Nature Communications|January 31, 2025
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanomaMengzhu Sun, Laure Garnier, Romane Chevalier, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Pageof 32

Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
Cancer Research|March 13, 2015
Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulinAleksandra M Dudek-Perić, Gabriela B Ferreira, Angelika Muchowicz, et al.
Science Advances|July 19, 2024
Targeting conserved TIM3<sup>+</sup>VISTA<sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapyIsaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.
Cancer Research Communications|April 20, 2026
Prognostic and Predictive Value of the Clearseq1-4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell CarcinomaLisa Kinget, Edward Scott McTaggart, Octavie Demeulenaere, et al.
Cell Death and Differentiation|August 28, 2021
Stress-induced inflammation evoked by immunogenic cell death is blunted by the IRE1α kinase inhibitor KIRA6 through HSP60 targetingNicole Rufo, Dimitris Korovesis, Sofie Van Eygen, et al.
Genes and Immunity|March 7, 2026
Immuno-molecular features and therapeutic implications of brain metastases in clear cell renal cell carcinoma patientsI Roodhooft, L Kinget, G Mammone, et al.
Cancer Immunology Research|November 24, 2021
Plexin-A4 Mediates Cytotoxic T-cell Trafficking and Exclusion in CancerWard Celus, Ana I Oliveira, Silvia Rivis, et al.
Cell Reports|April 7, 2016
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityTania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancerJenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, et al.
Nature Communications|January 31, 2025
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanomaMengzhu Sun, Laure Garnier, Romane Chevalier, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Pageof 32